Covetrus Announces a $250 Million Convertible Preferred Equity Investment by Clayton, Dubilier & Rice
Additional capital strengthens the Company’s financial profile and enables management to execute against strategic growth objectives.
Additional capital strengthens the Company’s financial profile and enables management to execute against strategic growth objectives.
Covetrus is aiming to simplify the prescribing process for preventatives with a new application, Script Assist.
Enhancing Patient Compliance With Covetrus Script Assist Read More»
Covetrus released select preliminary first quarter ended March 31, 2020 financial results and provided an update on its operations
Covetrus is embedding secure video teleconferencing capabilities across the company’s global suite of PIMS, client communications and prescription management solutions.
Covetrus Integrates Telemedicine Capabilities Across Its Global Technology Portfolio Read More»
Originally published by Reuters on
Caged in pet owners stockpile supplies for coronavirus lockdowns Read More»
Covetrus announced that it has completed the sale of its scil animal care business to Heska Corporation.
Covetrus Completes Sale of scil animal care to Heska Read More»